OSTİM Technical University Library

Sepetiniz boş.

Minimally Invasive Glaucoma Surgery.

Yazar:Sng, Chelvin C. A
Katkıda bulunan(lar):Barton, Keith
Materyal türü: KonuKonuYayıncı: Singapore : Springer Singapore Pte. Limited, 2020Telif hakkı tarihi: �2021Tanım: 1 online resource (203 pages)İçerik türü:text Ortam türü:computer Taşıyıcı türü: online resourceISBN: 9789811556326Tür/Form:Electronic books.Ek fiziksel biçimler:Print version:: Minimally Invasive Glaucoma SurgeryLOC classification: RE1-994Çevrimiçi kaynaklar: Click to View
İçindekiler:
Intro -- Foreword -- Contents -- About the Editors -- 1: Overview of MIGS -- 1.1 Trabecular Meshwork MIGS Devices and Techniques -- 1.2 Subconjunctival MIGS Devices -- 1.3 Suprachoroidal MIGS Devices -- 1.4 Cyclophotocoagulation (CPC) Procedures -- 1.5 Overview Summary -- References -- 2: Anatomy of the Aqueous Outflow Drainage Pathways -- 2.1 Introduction -- 2.2 Aqueous Humour Outflow -- 2.3 Trabecular Meshwork -- 2.4 Schlemm's Canal -- 2.5 Uveoscleral Outflow -- 2.6 Physiological Characteristics of Unconventional Outflow -- 2.7 Conjunctival Lymphatic System -- 2.8 Conclusions -- References -- 3: iStent: Trabecular Micro-Bypass Stent -- 3.1 Device Design -- 3.2 Patient Selection -- 3.3 Surgical Technique -- 3.3.1 Avoiding Complications and Surgical Pearls -- 3.3.2 Postoperative Management -- 3.4 Safety, Efficacy, and Clinical Results -- 3.4.1 iStent Trabecular Micro-Bypass Stent -- 3.4.2 iStent inject -- 3.5 Off-Label Use -- 3.6 Conclusion -- References -- 4: Ab-Interno Trabeculotomy -- 4.1 Introduction -- 4.2 Trabectome Device -- 4.3 Trabectome Procedure -- 4.4 Surgical Planning -- 4.4.1 Target IOP -- 4.4.2 Trabectome Can Be Performed in Patients with Narrow Angles -- 4.4.3 Contraindications -- 4.5 Results of Trabectome -- 4.5.1 Quality of Evidence -- 4.5.2 Clinical Efficacy -- 4.5.2.1 Trabectome-Alone -- 4.5.2.2 Trabectome-Alone Versus Trabeculectomy with Mitomycin C -- 4.5.2.3 Phaco-Trabectome Versus Trabectome-Alone -- 4.5.3 Phaco-Trabectome Versus Phaco-iStent -- 4.5.4 Preoperative Glaucoma Severity on Surgical Outcome -- 4.5.5 Other Potential Factors Affecting Efficacy -- 4.5.5.1 Does Prior Ineffective Selective Laser Trabeculoplasty (SLT) Alter Trabectome Outcomes? -- 4.5.5.2 Trabectome for Patients with Secondary Open-Angle Glaucoma.
4.5.5.3 Trabectome Can Be Performed in Patients with Previous Failed Trabeculectomy -- 4.5.5.4 Intraoperative Prognosticator for Postoperative Outcome -- 4.6 Complications of Trabectome -- 4.7 After Trabectome Has Failed -- 4.7.1 Does Trabectome Surgery Impact Future Glaucoma Surgery Outcomes? -- 4.7.2 Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) Procedure as a Potential Treatment Option After Failed Trabectome Surgery -- 4.8 Conclusion -- References -- 5: Hydrus Microstent -- 5.1 Introduction -- 5.2 Material/Design -- 5.2.1 Mechanism of Action -- 5.3 Ex Vivo Testing -- 5.4 Surgical Technique -- 5.5 Site of Implantation -- 5.6 Patients -- 5.7 Efficacy -- 5.8 Safety -- 5.9 Conclusion -- References -- 6: XEN Gel Implant -- 6.1 Device Design and Evolution -- 6.2 Patient Selection -- 6.3 Surgical Technique -- 6.3.1 Avoiding Complications and Surgical Pearls -- 6.3.2 Postoperative Management -- 6.4 Safety, Efficacy, and Clinical Results -- 6.5 Off-Label Use -- 6.6 Conclusion -- References -- 7: PRESERFLO MicroShunt -- 7.1 Introduction -- 7.2 Device Design and Development -- 7.3 Development of SIBS -- 7.4 Clinical Data -- 7.5 Patient Selection -- 7.6 Surgical Technique -- 7.7 Complications -- 7.7.1 Intraoperative Complications -- 7.7.2 Early Postoperative Complications -- 7.7.3 Late Complications -- 7.8 Conclusion -- References -- 8: Suprachoroidal MIGS Devices -- 8.1 Introduction -- 8.2 Physiology of the Suprachoroidal Outflow Pathway -- 8.3 Early Surgical Approaches -- 8.4 Ab-Externo Suprachoroidal Devices -- 8.5 Ab-Interno Suprachoroidal MIGS Devices -- 8.5.1 CyPass Micro-Stent -- 8.5.1.1 Surgical Technique -- Poor Visualization of the Anterior Chamber Angle -- Resistance Encountered During Implantation -- Position of Device Too Anterior -- Position of Device Too Posterior.
8.5.1.2 Mechanism of Action -- 8.5.1.3 Efficacy -- 8.5.1.4 Complications -- Intra-operative Complications -- Post-operative Complications -- Inflammation -- Hypotony -- IOP Spikes -- Hyphaema -- Deterioration in Vision (Loss of ≥2 Lines of BCVA) -- Device Occlusion -- Device Malposition -- Additional Glaucoma Surgery -- Corneal Endothelial Cell Loss and Corneal Decompensation -- Cataract Progression -- 8.5.2 iStent Supra -- 8.5.2.1 Implantation Technique -- 8.5.2.2 Efficacy and Safety -- 8.5.3 MINIject -- 8.5.3.1 Implantation Technique -- 8.5.3.2 Efficacy and Safety -- References -- 9: New Modalities of Cycloablation and High-Intensity-Focused Ultrasound -- 9.1 Introduction -- 9.2 Transscleral Diode Cyclophotocoagulation (TSCPC) -- 9.2.1 Procedure -- 9.2.2 Indications -- 9.2.3 Results -- 9.2.4 Complications -- 9.3 Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) -- 9.3.1 Procedure -- 9.3.2 Indications -- 9.3.3 MP-TSCPC vs. TSCPC -- 9.3.4 Results -- 9.3.5 Complications -- 9.4 High-Intensity Focused Ultrasound (HIFU) -- 9.4.1 Procedure -- 9.4.2 Mechanism -- 9.4.3 Results -- 9.4.4 Complications -- 9.5 Conclusion -- References -- 10: Controversies in the Use of MIGS -- 10.1 Introduction -- 10.2 Phaco Alone Versus Phaco/MIGS, Is It Worth It? -- 10.3 Trabecular Meshwork and Canal-Based Procedures: Cut Versus Stent Versus Dilate -- 10.4 Endothelial Cell Loss and MIGS -- 10.5 Is the Suprachoroidal Space Dead? -- 10.6 The Great Debate: Subconjunctival MIGS and Trabeculectomy -- References -- 11: Globalization of MIGS -- 11.1 Introduction -- 11.2 Cost -- 11.3 Distribution Channels -- 11.4 Surgical Training -- 11.5 Patients -- 11.6 Regulatory Considerations and Other Concerns -- 11.7 Conclusion -- References -- Appendix A: iStent Trabecular Micro-Bypass Stent Implantation Narrative Instructions.
Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation (Left Eye Example) -- Step 6: Viscoelastic Removal -- Appendix B: iStent inject Implantation Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix C: iStent Supra Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix D: Trabectome -- Step 1: Clear Corneal Incision -- Step 2: Lower Anterior Chamber Intraocular Pressure to Visualize Schlemm's Canal -- Step 3: Microscope Tilt and Head -- Step 4: Goniolens Placement -- Step 5: Removal of Trabecular Meshwork -- Step 6: Irrigate, Aspirate, and Suture (With or Without Phaco) -- Appendix E: Hydrus Microstent Procedure Steps -- Step 1 -- Step 2 -- Step 3 -- Step 4 -- Step 5 -- Step 6 -- Step 7 -- Step 8 -- Step 9 -- Appendix F: XEN Gel Implant -- Appendix G: PRESERFLO MicroShunt Glaucoma Device Surgical Technique -- Preparation of PRESERFLO MicroShunt.
Bu kütüphanenin etiketleri: Kütüphanedeki eser adı için etiket yok. Etiket eklemek için oturumu açın.
    Ortalama derecelendirme: 0.0 (0 oy)
Bu kayda ilişkin materyal yok

Intro -- Foreword -- Contents -- About the Editors -- 1: Overview of MIGS -- 1.1 Trabecular Meshwork MIGS Devices and Techniques -- 1.2 Subconjunctival MIGS Devices -- 1.3 Suprachoroidal MIGS Devices -- 1.4 Cyclophotocoagulation (CPC) Procedures -- 1.5 Overview Summary -- References -- 2: Anatomy of the Aqueous Outflow Drainage Pathways -- 2.1 Introduction -- 2.2 Aqueous Humour Outflow -- 2.3 Trabecular Meshwork -- 2.4 Schlemm's Canal -- 2.5 Uveoscleral Outflow -- 2.6 Physiological Characteristics of Unconventional Outflow -- 2.7 Conjunctival Lymphatic System -- 2.8 Conclusions -- References -- 3: iStent: Trabecular Micro-Bypass Stent -- 3.1 Device Design -- 3.2 Patient Selection -- 3.3 Surgical Technique -- 3.3.1 Avoiding Complications and Surgical Pearls -- 3.3.2 Postoperative Management -- 3.4 Safety, Efficacy, and Clinical Results -- 3.4.1 iStent Trabecular Micro-Bypass Stent -- 3.4.2 iStent inject -- 3.5 Off-Label Use -- 3.6 Conclusion -- References -- 4: Ab-Interno Trabeculotomy -- 4.1 Introduction -- 4.2 Trabectome Device -- 4.3 Trabectome Procedure -- 4.4 Surgical Planning -- 4.4.1 Target IOP -- 4.4.2 Trabectome Can Be Performed in Patients with Narrow Angles -- 4.4.3 Contraindications -- 4.5 Results of Trabectome -- 4.5.1 Quality of Evidence -- 4.5.2 Clinical Efficacy -- 4.5.2.1 Trabectome-Alone -- 4.5.2.2 Trabectome-Alone Versus Trabeculectomy with Mitomycin C -- 4.5.2.3 Phaco-Trabectome Versus Trabectome-Alone -- 4.5.3 Phaco-Trabectome Versus Phaco-iStent -- 4.5.4 Preoperative Glaucoma Severity on Surgical Outcome -- 4.5.5 Other Potential Factors Affecting Efficacy -- 4.5.5.1 Does Prior Ineffective Selective Laser Trabeculoplasty (SLT) Alter Trabectome Outcomes? -- 4.5.5.2 Trabectome for Patients with Secondary Open-Angle Glaucoma.

4.5.5.3 Trabectome Can Be Performed in Patients with Previous Failed Trabeculectomy -- 4.5.5.4 Intraoperative Prognosticator for Postoperative Outcome -- 4.6 Complications of Trabectome -- 4.7 After Trabectome Has Failed -- 4.7.1 Does Trabectome Surgery Impact Future Glaucoma Surgery Outcomes? -- 4.7.2 Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) Procedure as a Potential Treatment Option After Failed Trabectome Surgery -- 4.8 Conclusion -- References -- 5: Hydrus Microstent -- 5.1 Introduction -- 5.2 Material/Design -- 5.2.1 Mechanism of Action -- 5.3 Ex Vivo Testing -- 5.4 Surgical Technique -- 5.5 Site of Implantation -- 5.6 Patients -- 5.7 Efficacy -- 5.8 Safety -- 5.9 Conclusion -- References -- 6: XEN Gel Implant -- 6.1 Device Design and Evolution -- 6.2 Patient Selection -- 6.3 Surgical Technique -- 6.3.1 Avoiding Complications and Surgical Pearls -- 6.3.2 Postoperative Management -- 6.4 Safety, Efficacy, and Clinical Results -- 6.5 Off-Label Use -- 6.6 Conclusion -- References -- 7: PRESERFLO MicroShunt -- 7.1 Introduction -- 7.2 Device Design and Development -- 7.3 Development of SIBS -- 7.4 Clinical Data -- 7.5 Patient Selection -- 7.6 Surgical Technique -- 7.7 Complications -- 7.7.1 Intraoperative Complications -- 7.7.2 Early Postoperative Complications -- 7.7.3 Late Complications -- 7.8 Conclusion -- References -- 8: Suprachoroidal MIGS Devices -- 8.1 Introduction -- 8.2 Physiology of the Suprachoroidal Outflow Pathway -- 8.3 Early Surgical Approaches -- 8.4 Ab-Externo Suprachoroidal Devices -- 8.5 Ab-Interno Suprachoroidal MIGS Devices -- 8.5.1 CyPass Micro-Stent -- 8.5.1.1 Surgical Technique -- Poor Visualization of the Anterior Chamber Angle -- Resistance Encountered During Implantation -- Position of Device Too Anterior -- Position of Device Too Posterior.

8.5.1.2 Mechanism of Action -- 8.5.1.3 Efficacy -- 8.5.1.4 Complications -- Intra-operative Complications -- Post-operative Complications -- Inflammation -- Hypotony -- IOP Spikes -- Hyphaema -- Deterioration in Vision (Loss of ≥2 Lines of BCVA) -- Device Occlusion -- Device Malposition -- Additional Glaucoma Surgery -- Corneal Endothelial Cell Loss and Corneal Decompensation -- Cataract Progression -- 8.5.2 iStent Supra -- 8.5.2.1 Implantation Technique -- 8.5.2.2 Efficacy and Safety -- 8.5.3 MINIject -- 8.5.3.1 Implantation Technique -- 8.5.3.2 Efficacy and Safety -- References -- 9: New Modalities of Cycloablation and High-Intensity-Focused Ultrasound -- 9.1 Introduction -- 9.2 Transscleral Diode Cyclophotocoagulation (TSCPC) -- 9.2.1 Procedure -- 9.2.2 Indications -- 9.2.3 Results -- 9.2.4 Complications -- 9.3 Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) -- 9.3.1 Procedure -- 9.3.2 Indications -- 9.3.3 MP-TSCPC vs. TSCPC -- 9.3.4 Results -- 9.3.5 Complications -- 9.4 High-Intensity Focused Ultrasound (HIFU) -- 9.4.1 Procedure -- 9.4.2 Mechanism -- 9.4.3 Results -- 9.4.4 Complications -- 9.5 Conclusion -- References -- 10: Controversies in the Use of MIGS -- 10.1 Introduction -- 10.2 Phaco Alone Versus Phaco/MIGS, Is It Worth It? -- 10.3 Trabecular Meshwork and Canal-Based Procedures: Cut Versus Stent Versus Dilate -- 10.4 Endothelial Cell Loss and MIGS -- 10.5 Is the Suprachoroidal Space Dead? -- 10.6 The Great Debate: Subconjunctival MIGS and Trabeculectomy -- References -- 11: Globalization of MIGS -- 11.1 Introduction -- 11.2 Cost -- 11.3 Distribution Channels -- 11.4 Surgical Training -- 11.5 Patients -- 11.6 Regulatory Considerations and Other Concerns -- 11.7 Conclusion -- References -- Appendix A: iStent Trabecular Micro-Bypass Stent Implantation Narrative Instructions.

Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation (Left Eye Example) -- Step 6: Viscoelastic Removal -- Appendix B: iStent inject Implantation Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix C: iStent Supra Narrative Instructions -- Step 1: Patient Positioning and Setup -- Step 2: Adjusting Microscope and Identifying Landmarks -- Step 3: Accessing Anterior Chamber -- Step 4: Accessing Implantation Site -- Step 5: Stent Implantation -- Step 6: Viscoelastic Removal -- Appendix D: Trabectome -- Step 1: Clear Corneal Incision -- Step 2: Lower Anterior Chamber Intraocular Pressure to Visualize Schlemm's Canal -- Step 3: Microscope Tilt and Head -- Step 4: Goniolens Placement -- Step 5: Removal of Trabecular Meshwork -- Step 6: Irrigate, Aspirate, and Suture (With or Without Phaco) -- Appendix E: Hydrus Microstent Procedure Steps -- Step 1 -- Step 2 -- Step 3 -- Step 4 -- Step 5 -- Step 6 -- Step 7 -- Step 8 -- Step 9 -- Appendix F: XEN Gel Implant -- Appendix G: PRESERFLO MicroShunt Glaucoma Device Surgical Technique -- Preparation of PRESERFLO MicroShunt.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2022. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments on this title.

yorum yazmak için.

Ziyaretçi Sayısı

Destekleyen Koha